Collegium Pharmaceutical Inc (COLL)
37.51
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
37.53
+0.02
(+0.05%)
After-Hours: 20:00
Collegium Pharmaceutical Debt to Equity Ratio: 3.414 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.414 |
| September 30, 2023 | 3.975 |
| June 30, 2023 | 3.759 |
| March 31, 2023 | 4.442 |
| December 31, 2022 | 3.598 |
| September 30, 2022 | 3.669 |
| June 30, 2022 | 3.776 |
| March 31, 2022 | 3.920 |
| December 31, 2021 | 1.232 |
| September 30, 2021 | 1.042 |
| June 30, 2021 | 1.080 |
| March 31, 2021 | 1.676 |
| December 31, 2020 | 1.382 |
| September 30, 2020 | 1.546 |
| June 30, 2020 | 1.778 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.034 |
| December 31, 2019 | 0.1315 |
| September 30, 2019 | 0.1365 |
| June 30, 2019 | 0.134 |
| March 31, 2019 | 0.1332 |
| December 31, 2018 | 0.1256 |
| September 30, 2018 | 0.1625 |
| June 30, 2018 | 0.1391 |
| March 31, 2018 | 0.1266 |
| December 31, 2017 | 0.0142 |
| September 30, 2017 | 0.0223 |
| June 30, 2017 | 0.0295 |
| March 31, 2017 | 0.0304 |
| December 31, 2016 | 0.0307 |
| September 30, 2016 | 0.0648 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1315
Minimum
Dec 2019
4.442
Maximum
Mar 2023
2.249
Average
1.778
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Catalyst Pharmaceuticals Inc | 0.00 |
| Immunogen Inc (DELISTED) | 0.1284 |
| AnaptysBio Inc | 0.00 |
| Recursion Pharmaceuticals Inc | 0.0025 |
| Nuvalent Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.143B |
| Total Liabilities (Quarterly) | 947.88M |
| Shareholders Equity (Quarterly) | 195.43M |
| Current Ratio | 1.174 |
| Net Debt Paydown Yield | 1.15% |